Adding cisplatin to radiation therapy (RT) did not statistically improve relapse-free survival (RFS) or overall survival (OS) while increasing the incidence of grade 3 and 4 adverse events (AEs) in patients with cervical cancer who have…
Adding cisplatin to radiation therapy (RT) did not statistically improve relapse-free survival (RFS) or overall survival (OS) while increasing the incidence of grade 3 and 4 adverse events (AEs) in patients with cervical cancer who have…